The role of the cardiovascular specialist in the prevention of cardiovascular diseases - executive summary.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Canadian Journal of Cardiology

• Publication date

  1999-12-01

• Fields of study

  Medicine

• Identifiers
  PMID 10692651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population.

  2017cites this paper
• Evaluation of a workplace health program to reduce coronary risk factors

  2008cites this paper
• Estimating LDL ApoB: infomania or clinical advance?

  2008cites this paper
• Apolipoproteins as markers and managers of coronary risk.

  2006cites this paper
• Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel

  2006cites this paper
• Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia.

  2006cites this paper
• Apolipoprotein A1 and B.

  2006cites this paper
• Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol

  2005cites this paper
• The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk

  2004cites this paper
• Comparison of the Associations of Apolipoprotein B and Non–High-Density Lipoprotein Cholesterol With Other Cardiovascular Risk Factors in Patients With the Metabolic Syndrome in the Insulin Resistance Atherosclerosis Study

  2004cites this paper
• Apolipoprotein B and apolipoprotein A‐I: risk indicators of coronary heart disease and targets for lipid‐modifying therapy

  2004cites this paper
• Approach to lipoprotein management in 2001 National Cholesterol Guidelines.

  2002cites this paper
• How, when, and why to use apolipoprotein B in clinical practice.

  2002cites this paper
• Apolipoprotein B versus lipoprotein lipids: vital lessons from the AFCAPS/TexCAPS trial.

  2001influential citation
• High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol.

  2001cites this paper
• Familial combined hyperlipidemia and insulin resistance : distant relatives linked by intra-abdominal fat?

  2001cites this paper
• Antioxidant supplements and simvastatin-niacin therapy.

  2001cites this paper
• International Journal of Biological & Medical Research Apolipoprotein B (xbai) Allele Frequencies in an Egyptian Population: Impact on Blood Lipids a B C a B Original Article

  year unknowncites this paper